5b. VACCINATION: The inactivation process

Home Knowledge 5b. VACCINATION: The inactivation process

5b. VACCINATION: The inactivation process


 

As shown in this video, the complex inactivation process of Chlamydia used in INMEVA® vaccine allows the outer membrane proteins to be preserved:

 

 


This, combined with a high antigenic load and the selection of the appropriate adjuvant, gives INMEVA® a high level of efficacy.

 

 

PREVIOUS ARTICLE          NEXT ARTICLE

 


© Laboratorios Hipra, S.A. All Rights Reserved.
No part of these contents may be reproduced, copied, modified or adapted, without the prior written consent of HIPRA.

 

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}